NCIt definition : A small molecule inhibitor of the receptor tyrosine kinases (RTKs) anaplastic lymphoma
kinase (ALK) and nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), with potential
antineoplastic activity. Upon administration, TAE684 binds to and inhibits ALK and
NPM-ALK tyrosine kinases, which leads to a disruption of ALK- and NPM-ALK mediated
signaling and eventually inhibits tumor cell growth in ALK- and NPM-ALK overexpressing
tumor cells. ALK belongs to the insulin receptor superfamily and plays an important
role in nervous system development. ALK dysregulation and gene rearrangements are
associated with a series of tumors. NPM-ALK is an oncogenic fusion protein associated
with ALK-positive anaplastic large cell lymphoma. ALK mutations are also associated
with acquired resistance to small molecule tyrosine kinase inhibitors.;
UNII : EH1713MN4K;
InChIKey : QQWUGDVOUVUTOY-UHFFFAOYSA-N;
CAS number : 761439-42-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 761439-42-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;